CeriBell gains FDA clearance for its continuous delirium monitoring solution, boosting its AI-driven EEG platform and expanding its role in critical care.

First clinical trial published demonstrating safety and efficacy of a bilateral continuous EEG monitoring system Clinically relevant findings were identified in 88% of patients High-quality, durable ...

Novel technology paves the way for use of the company's industry-leading point-of-care electroencephalography (EEG) system to ...

Pediatric neurocritical care has evolved into a specialised field dedicated to the intensive management of critically ill children with acute neurological conditions. A cornerstone of this management ...

Aware captures an unprecedented amount of brain data, delivering personalized, AI-driven health and human performance insights into the body and brain in a device you wear in your daily life.” — Sam ...

SUNNYVALE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with ...

Researchers have created a hairlike device for long-term, non-invasive monitoring of the brain's electrical activity. The lightweight and flexible electrode attaches directly to the scalp and delivers ...

-- The Australian-developed Minder system is an implantable device for continuous monitoring of brain activity in patients with epilepsy, developed to address the shortcomings in current ...

The technology paves the way for the use of the company's point-of-care electroencephalography system to address a long unmet ...

The lightweight, flexible, bioadhesive electrode, which looks like a strand of hair, attaches directly to the scalp and delivers stable, high-quality recordings of the brain’s signals. UNIVERSITY PARK ...

The Australian-developed Minder system is an implantable device for continuous monitoring of brain activity in patients with epilepsy, developed to address the shortcomings in current ...